NAS:NBIX (USA)
Â
Ordinary Shares
$
133.70
+1.66 (+1.26%)
10:08 PM EST
New Key Statistics Module, Z-Score and F-Score
NAS:NBIX Key Ratios
| Market Cap $ M | 13,447.61 |
| Enterprise Value $ M | 12,669.40 |
| P/E(ttm) | 55.23 |
| PE Ratio without NRI | 33.41 |
| Forward PE Ratio | 25.94 |
| Price/Book | 5.91 |
| Price/Sales | 7.10 |
| Price/Free Cash Flow | 37.88 |
| Price/Owner Earnings | 59.85 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,887.00 |
| EPS (TTM) $ | 2.42 |
| Beneish M-Score | -2.2 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 40.20 |
| y-y EBITDA Growth Rate % | 48.20 |
| EV-to-EBIT | 37.61 |
| EV-to-EBITDA | 35.37 |
| PEG | 0.83 |
| Shares Outstanding M | 100.58 |
| Net Margin (%) | 13.23 |
| Operating Margin % | 20.92 |
| Pre-tax Margin (%) | 17.60 |
| Quick Ratio | 2.40 |
| Current Ratio | 2.45 |
| ROA % (ttm) | 9.29 |
| ROE % (ttm) | 13.17 |
| ROIC % (ttm) | 20.57 |
| Dividend Yield % | -- |
| Altman Z-Score | 9.02 |
| Piotroski F-Score | 5.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | Y |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | N |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | Y |
NBIX Number of Guru Trades
NBIX Volume of Guru Trades
Gurus Latest Trades with NAS:NBIX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:NBIX is held by these investors
Total 5
Neurocrine Biosciences Inc Insider Transactions
No Available Data
News about NAS:NBIX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers